Related Experiment Video

Updated: Jul 24, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Clinical activities that contributed to the effectiveness of a cardiologist-pharmacist collaborative care model in

Zheng Kang Lum1, Kwee Keng Kng2, Cynthia Ee Mei Goh2

  • 1Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore.

The International Journal of Pharmacy Practice
|July 6, 2023
PubMed

Insights

Pharmacist-involved collaborative care significantly improved glycated haemoglobin (HbA1c) in Type 2 diabetes patients. Health education and medication adjustments were key drivers of this improvement.

Area of Science:

  • Endocrinology
  • Pharmacotherapy
  • Cardiovascular Medicine

Background:

  • Type 2 diabetes management requires continuous monitoring of glycated haemoglobin (HbA1c).
  • Pharmacist-involved collaborative care (PCC) models are emerging as a strategy to improve patient outcomes.
  • The association between PCC, clinical activities, and HbA1c changes needs further elucidation.

Purpose of the Study:

  • To evaluate the change in HbA1c in patients receiving PCC compared to cardiologist care (CC).
  • To identify clinical activities associated with HbA1c improvement.
  • To explore moderators influencing the PCC-HbA1c relationship.

Main Methods:

  • Retrospective cohort study of 420 adults with Type 2 diabetes and cardiovascular disease over 12 months.
  • 1:1 matching of PCC patients with CC patients based on baseline HbA1c.
  • Linear mixed models and linear regression analyzed HbA1c changes and associated clinical activities.

Main Results:

  • The PCC group showed a significant mean HbA1c decrease of -0.4% at 6 and 12 months, compared to -0.1% and -0.2% in the CC group (P<0.001).
  • Higher frequencies of lifestyle counseling, health education, medication adherence reinforcement, and problem resolution were observed in the PCC group (P<0.001).

Conclusions:

  • Pharmacist-involved collaborative care leads to significant improvements in HbA1c for Type 2 diabetes patients.
  • Health education and medication adjustments are critical components driving HbA1c reduction within PCC.
  • PCC offers a valuable model for enhancing diabetes management and cardiovascular health.
Abstract

Keywords:
cardiovascular riskclinical activitiescollaborative carediabetespharmacist clinic

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

662
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.3K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
115
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
598